Literature DB >> 12399802

Pancreatic cancer.

Theresa Pluth Yeo1, Ralph H Hruban, Steven D Leach, Robb E Wilentz, Taylor A Sohn, Scott E Kern, Christine A Iacobuzio-Donahue, Anirban Maitra, Michael Goggins, Marcia I Canto, Ross A Abrams, Daniel Laheru, Elizabeth M Jaffee, Manuel Hidalgo, Charles J Yeo.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12399802     DOI： 10.1067/mcn.2002.129579

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  82 in total

1.  Recent developments in diagnosis of pancreatic cancer.

Authors:  Arjun S Takhar; Ponni Palaniappan; Rajpal Dhingsa; Dileep N Lobo
Journal:  BMJ       Date:  2004-09-18

Review 2.  The role of radiotherapy in locally advanced pancreatic carcinoma.

Authors:  Ruchika Gutt; Stanley L Liauw; Ralph R Weichselbaum
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

3.  Pancreatic cancer in the general population: Improvements in survival over the last decade.

Authors:  Taylor S Riall; William H Nealon; James S Goodwin; Dong Zhang; Yong-Fang Kuo; Courtney M Townsend; Jean L Freeman
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

4.  Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells.

Authors:  Yue Huang; Jun Fan; Jing Yang; Guo-Zhang Zhu
Journal:  Mol Cell Biochem       Date:  2007-10-12       Impact factor: 3.396

Review 5.  Target discovery and validation in pancreatic cancer.

Authors:  Robert M Beaty; Mads Gronborg; Jonathan R Pollack; Anirban Maitra
Journal:  Methods Mol Biol       Date:  2007

6.  Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growth.

Authors:  Martin Ligr; Xinyu Wu; Garrett Daniels; David Zhang; Huamin Wang; Cristina Hajdu; Jinhua Wang; Ruimin Pan; Zhiheng Pei; Lanjing Zhang; Marcovalerio Melis; Matthew R Pincus; John K Saunders; Peng Lee; Ruliang Xu
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

7.  Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.

Authors:  Soukaina Réjiba; Christelle Bigand; Céline Parmentier; Amor Hajri
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

8.  In vivo optical spectroscopy for improved detection of pancreatic adenocarcinoma: a feasibility study.

Authors:  William R Lloyd; Robert H Wilson; Seung Yup Lee; Malavika Chandra; Barbara McKenna; Diane Simeone; James Scheiman; Mary-Ann Mycek
Journal:  Biomed Opt Express       Date:  2013-12-02       Impact factor: 3.732

9.  Ape1/Ref-1 induces glial cell-derived neurotropic factor (GDNF) responsiveness by upregulating GDNF receptor alpha1 expression.

Authors:  Mi-Hwa Kim; Hong-Beum Kim; Samudra Acharya; Hong-Moon Sohn; Jae Yeoul Jun; In-Youb Chang; Ho Jin You
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

10.  Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.

Authors:  Timothy R Donahue; Kevork K Kazanjian; William H Isacoff; Howard A Reber; O Joe Hines
Journal:  J Gastrointest Surg       Date:  2010-03-23       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.